The $billion deal, announced last March, is one of two proposed transactions involving pharmacy companies before the Justice Department. There’s no dispute that a $48. Now, the question is whether one owes the other billions for the deal’s failure.
The merger consideration consisted of $48. I own ESRX in a TDAmeritrade account.
The transaction posts as: 1) sale of ESRX at $48. The $billion deal was expected to close Dec. Securities and Exchange Commission. The $billion merger between a pharmacy benefit manager and one of the largest health insurers in the country will be the first of its kind. Living or Working Abroad?
What do People Think About Us? Find Here All You Need to Know. A total of acquisitions came from private equity firms.
It has also divested asset. Louis-based pharmacy benefit management company, and the Connecticut-based health service corporation. Gurman said in a statement. Competition, not consolidation, is the right prescription for health insurance markets.
We manage your pharmacy plan, and we’re a pharmacy.